CHIEF-HF: Improvement in Heart Failure Symptoms at 12 Wk With Canagliflozin vs Placebo

Clinical Care Options (CCO) and Practicing Clinicians Exchange (PCE) ClinicalThought commentary with answers from expert faculty on frequently asked questions on SDOH in NVAF

Keith C. Ferdinand, MD, FACC, FAHA
Program Director David S. Kountz, MD Laura Ross, PA-C, CLS Released: May 26, 2022

Expert commentary on updates to the 2022 AHA/ACC/HFSA heart failure guidelines, from Clinical Care Options (CCO)

Lee R. Goldberg, MD, MPH, FACC Physicians: maximum of 0.5 AMA PRA Category 1 Credits™ Released: May 10, 2022 Expired: May 9, 2023

Clinical Care Options (CCO): Expert commentary covering new data in HFpEF diagnosis and treatment from ACC 2022 Annual Scientific Sessions

Lee R. Goldberg, MD, MPH, FACC Physicians: maximum of 0.5 AMA PRA Category 1 Credits™ Released: April 26, 2022 Expired: April 25, 2023

Clinical Care Options (CCO): Expert commentary covering new data in HFrEF management from ACC 2022, including SODIUM-HF, PROMPT-HF, DIAMOND, and EMPULSE

Lee R. Goldberg, MD, MPH, FACC Physicians: maximum of 0.5 AMA PRA Category 1 Credits™ Released: April 20, 2022 Expired: April 19, 2023